Kidwai Memorial Institute of Oncology, Bangalore Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2005
NCT00544986
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Alternative names

Kidwai Memorial Institute of Oncology, Bangalore, INDIA | Kidwai Memorial Istitute of Oncology

Active Ingredients

Drugs in Phase 4 Trials (1)

anastrozole (arimidex) (1 trial)

Drugs in Phase 2 Trials (2)

docetaxel (taxotere) (1 trial)

immuvac (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 4)

Hypersensitivity (Phase 4)

Mycobacterium Infections (Phase 2)

Prostatic Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3